lactose has been researched along with salicylates in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (50.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| León-Barúa, R; Tello-Casanova, R | 1 |
| Dillinger, P; Sarsúnová, M; Tölgyessy, J | 1 |
| Cadwallader, DE; Drinkard, JP | 1 |
| Jaiyeoba, KT; Spring, MS | 1 |
| Hersey, JA; Lai, FK; Rees, JE; Staniforth, JN | 1 |
| Nguyen, LT; Thiel, WJ | 1 |
| Dubois, A; Heman-Ackah, LM; Mysore, JV; Simon, PM; Wigginton, T; Zopf, D | 1 |
| Du, G; Huang, C; Li, Y; Ma, X; Xin, S; Xin, W; Zhang, D; Zhang, T; Zhang, X; Zhou, S; Zhou, Y | 1 |
| Du, G; He, Y; Ma, Y; Song, J; Wang, S; Wu, P; Yan, Y; Zhang, T; Zhang, W | 1 |
| Du, G; Li, Y; Ma, X; Ni, L; Sun, J; Xin, W; Zhang, D; Zhang, T; Zhang, X | 1 |
| Du, G; Huang, C; Ma, X; Xin, W; Zhang, D; Zhang, T; Zhang, W | 1 |
| Du, G; Sun, L; Wang, L; Wang, X; Wang, Y; Yang, H; Yang, S; Yu, Z; Yuan, T | 1 |
12 other study(ies) available for lactose and salicylates
| Article | Year |
|---|---|
[In vitro effect of 2 pharmaceutical preparations containing bismuth on the fermentative capacity of intestinal bacteria].
Topics: Antacids; Bacteria; Bismuth; Feces; Fermentation; Humans; In Vitro Techniques; Intestines; Lactose; Organometallic Compounds; Salicylates | 1985 |
[Determination of moisture in some compounds used for pharmaceutical purposes by method of scattering and decelerated of neutrons].
Topics: Aluminum Silicates; Citrates; Humidity; Lactose; Methods; Neutrons; Pharmaceutical Preparations; Salicylates; Sodium | 1969 |
Behavior of erythrocytes in various solvent systems. IV. Water-dimethylsulfoxide.
Topics: Adult; Bromides; Calcium Chloride; Citrates; Dimethyl Sulfoxide; Erythrocytes; Glucose; Glycols; Hemolysis; Humans; In Vitro Techniques; Iodides; Lactose; Male; Polyethylenes; Potassium; Propylene Glycols; Salicylates; Sodium; Sodium Chloride; Solutions; Water | 1967 |
The granulation of ternary mixtures: the effect of the wettability of the powders.
Topics: Boric Acids; Chemistry, Pharmaceutical; Kaolin; Lactose; Particle Size; Powders; Salicylates; Sulfanilamides; Surface-Active Agents; Wetting Agents | 1980 |
Interparticle forces in binary and ternary ordered powder mixes.
Topics: Adhesiveness; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Lactose; Particle Size; Powders; Salicylates; Salicylic Acid; Starch; Sucrose; Talc | 1982 |
Fluidized bed film coating of an ordered powder mixture to produce microencapsulated order units.
Topics: Capsules; Cellulose; Chemistry, Pharmaceutical; Excipients; Lactose; Particle Size; Powders; Salicylates; Salicylic Acid; Talc; Time Factors | 1984 |
Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound.
Topics: Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Disease Models, Animal; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lactose; Liver Function Tests; Macaca mulatta; Organometallic Compounds; Proton Pump Inhibitors; Salicylates; Sialic Acids | 1999 |
Methyl salicylate lactoside inhibits inflammatory response of fibroblast-like synoviocytes and joint destruction in collagen-induced arthritis in mice.
Topics: Animals; Ankle Joint; Antirheumatic Agents; Arthritis, Experimental; Cell Proliferation; Collagen; Humans; Inflammation; Inflammation Mediators; Lactose; Male; Mice; Mice, Inbred DBA; Rats; Rats, Wistar; Salicylates; Synovial Membrane; Tumor Necrosis Factor-alpha | 2014 |
Lack of dose dependent kinetics of methyl salicylate-2-O-β-D-lactoside in rhesus monkeys after oral administration.
Topics: Administration, Oral; Animals; Biological Availability; Dose-Response Relationship, Drug; Female; Kinetics; Lactose; Macaca mulatta; Male; Salicylates | 2015 |
Anti-inflammation effect of methyl salicylate 2-O-β-D-lactoside on adjuvant induced-arthritis rats and lipopolysaccharide (LPS)-treated murine macrophages RAW264.7 cells.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Disease Progression; Gaultheria; Humans; Interleukin-1beta; Lactose; Lipopolysaccharides; Macrophages; Male; MAP Kinase Signaling System; Mice; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats; Rats, Sprague-Dawley; Salicylates; Tumor Necrosis Factor-alpha | 2015 |
Preclinical pharmacokinetic evaluation and metabolites identification of methyl salicylate-2-O-β-d-lactoside in rats using LC-MS/MS and Q-TOF-MS methods.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biotransformation; Calibration; Chromatography, High Pressure Liquid; Feces; Lactose; Limit of Detection; Mass Spectrometry; Quality Control; Rats; Reproducibility of Results; Salicylates; Tissue Distribution | 2015 |
Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cell Count; Cytokines; Lactose; Lipopolysaccharides; Lung; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred BALB C; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Peroxidase; Phosphorylation; RAW 264.7 Cells; Salicylates | 2016 |